Literature DB >> 3955782

Amino acid membrane transport properties of L1210 cells resistant to cisplatin.

R B Gross, K J Scanlon.   

Abstract

A mouse L1210 leukemia cell line was made 18-fold resistant to the chemotherapeutic agent cisplatin. The drug resistant cells exhibited changes in morphologic and biochemical properties from the sensitive cells. Uptake of labeled cisplatin was only slightly decreased in the resistant cells. However, the exogenous methionine requirement for these cells was 18-fold less than for parent cells. This decrease in the methionine requirement was also associated with differences in both methionine metabolism and transport. Membrane transport analysis revealed different Kt and Vmax properties for methionine and a nonmetabolizable amino acid analogue between the two cell lines. In L1210 cells resistant to cisplatin, decreases in amino acid transport, plus changes in amino acid substrate specificities, may be related to a drug-membrane phenomenon which could be one mechanism of resistance to chemotherapeutic agents.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3955782

Source DB:  PubMed          Journal:  Chemioterapia        ISSN: 0392-906X


  10 in total

1.  Elevated expression of thymidylate synthase cycle genes in cisplatin-resistant human ovarian carcinoma A2780 cells.

Authors:  K J Scanlon; M Kashani-Sabet
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

2.  Development of alkylating agent-resistant human tumor cell lines.

Authors:  B A Teicher; E Frei
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

Review 3.  Mechanisms of cellular resistance to cisplatin.

Authors:  G A Hospers; N H Mulder; E G De Vries
Journal:  Med Oncol Tumor Pharmacother       Date:  1988

Review 4.  Resistance to cisplatin and analogues: mechanisms and potential clinical implications.

Authors:  A de Graeff; R J Slebos; S Rodenhuis
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

5.  Short-term cis-diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells.

Authors:  S C Mann; P A Andrews; S B Howell
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

6.  The role of methionine in methotrexate-sensitive and methotrexate-resistant mouse leukemia L1210 cells.

Authors:  K J Scanlon; M Kashani-Sabet; A R Cashmore; M Pallai; B A Moroson; M Saketos
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

7.  Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells.

Authors:  K J Scanlon; E M Newman; Y Lu; D G Priest
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

8.  Relationship between folate-binding protein expression and cisplatin sensitivity in ovarian carcinoma cell lines.

Authors:  F Ottone; S Miotti; C Bottini; M Bagnoli; P Perego; M I Colnaghi; S Ménard
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

9.  Characterization of acquired resistance to cis-diamminedichloroplatinum(II) in mouse leukemia cell lines.

Authors:  T Tashiro; Y Sato
Journal:  Jpn J Cancer Res       Date:  1992-02

10.  Factors affecting platinum concentrations in human surgical tumour specimens after cisplatin.

Authors:  D J Stewart; J M Molepo; R M Green; V A Montpetit; H Hugenholtz; A Lamothe; N Z Mikhael; M D Redmond; M Gadia; R Goel
Journal:  Br J Cancer       Date:  1995-03       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.